Автор туралы ақпарат

KRAVCHENKO, A. V

Шығарылым Бөлім Атауы Файл
№ 4 (2012) Articles HIV AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASES
№ 2 (2013) Articles ROLE OF RISK FACTORS IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN HIV-INFECTED PATIENTS WITH THE NATURAL HISTORY OF HIV INFECTION
№ 4 (2013) Articles GENDER FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR RISKS IN HIV-INFECTED PATIENTS NOT RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
№ 6 (2014) Articles DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
№ 1 (2015) Articles Hepatotoxicity of antiretroviral therapy in HIV-infected patients
№ 5 (2015) Articles The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
№ 6 (2015) Articles HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
№ 3 (2016) Articles Genetic markers for HIV infection progression and secondary diseases development
№ 5 (2016) Articles The efficacy and safety of Elpivirine as part of a 24-48-week antiretroviral therapy regimen versus an Efavirenz-containing regimen
№ 1 (2011) Articles MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DURING ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION
№ 2 (2011) Articles THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
№ 3 (2018) Articles Bacterial excretion in patients with HIV infection and tuberculosis

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>